Found: 99
Select item for more details and to access through your institution.
The Role of Cytotoxic Chemotherapy in Prostate Cancer: A Critical Reevaluation 20 Years Later.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 14, p. 1854
- By:
- Publication type:
- Article
A phase II trial of estramustine and etoposide in hormone refractory prostate cancer: A Southwest Oncology Group trial (SWOG 9407).
- Published in:
- Prostate, 2001, v. 46, n. 4, p. 257, doi. 10.1002/1097-0045(20010301)46:4<257::AID-PROS1031>3.0.CO;2-4
- By:
- Publication type:
- Article
Suramin, an active drug for prostate cancer: interim observations in a phase I trial.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Suramin, an Active Nonhormonal Cytotoxic Drug for Treatment of Prostate Cancer: Compelling Reasons for Testing in Patients With Hormone-Refractory Breast Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1992, v. 84, n. 1, p. 3
- By:
- Publication type:
- Article
High-Dose Recombinant Interleukin-2 Alone: A Regimen With Limited Activity in the Treatment of Advanced Renal Cell Carcinoma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1990, v. 82, n. 14, p. 1202, doi. 10.1093/jnci/82.14.1202
- By:
- Publication type:
- Article
The effect of clinical trial participation versus non-participation on overall survival in men receiving first-line docetaxel-containing chemotherapy for metastatic castration-resistant prostate cancer.
- Published in:
- BJU International, 2012, v. 110, n. 11b, p. E575, doi. 10.1111/j.1464-410X.2012.11286.x
- By:
- Publication type:
- Article
The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-up.
- Published in:
- BJU International, 2012, v. 109, n. 1, p. 32, doi. 10.1111/j.1464-410X.2011.10422.x
- By:
- Publication type:
- Article
Long-term overall survival and metastasis-free survival for men with prostate-specific antigen-recurrent prostate cancer after prostatectomy: analysis of the Center for Prostate Disease Research National Database.
- Published in:
- BJU International, 2011, v. 108, n. 3, p. 378, doi. 10.1111/j.1464-410X.2010.09878.x
- By:
- Publication type:
- Article
Outcomes of patients after aborted radical cystectomy for intraoperative findings of metastatic disease.
- Published in:
- BJU International, 2008, v. 102, n. 11, p. 1539, doi. 10.1111/j.1464-410X.2008.07877.x
- By:
- Publication type:
- Article
Natural History of Progression After PSA Elevation Following Radical Prostatectomy.
- Published in:
- JAMA: Journal of the American Medical Association, 1999, v. 281, n. 17, p. 1591, doi. 10.1001/jama.281.17.1591
- By:
- Publication type:
- Article
A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE).
- Published in:
- 2017
- By:
- Publication type:
- journal article
Neutropenia, neutrophilia, and neutrophil–lymphocyte ratio as prognostic markers in patients with metastatic castration-resistant prostate cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221100022
- By:
- Publication type:
- Article
Erratum: Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer.
- Published in:
- 2009
- By:
- Publication type:
- Correction Notice
Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer.
- Published in:
- Nature Medicine, 2009, v. 15, n. 5, p. 559, doi. 10.1038/nm.1944
- By:
- Publication type:
- Article
A phase I study of the antibody drug conjugate ASG-5ME, an SLC44A4-targeting antibody carrying auristatin E, in metastatic castration-resistant prostate cancer.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 5, p. 1052, doi. 10.1007/s10637-019-00731-5
- By:
- Publication type:
- Article
Is There a "Trial Effect" on Outcome of Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib?
- Published in:
- Cancer Research & Treatment, 2016, v. 48, n. 1, p. 281, doi. 10.4143/crt.2014.289
- By:
- Publication type:
- Article
POINT: Chemotherapy vs Abiraterone for the Initial Management of Metastatic Prostate Cancer.
- Published in:
- Oncology (08909091), 2018, v. 32, n. 5, p. 223
- By:
- Publication type:
- Article
Chemotherapy in Prostate Cancer Beyond Metastatic CRPC.
- Published in:
- Oncology (08909091), 2015, v. 29, n. 12, p. 964
- By:
- Publication type:
- Article
LHRH Antagonists vs LHRH Agonists: Which Is More Beneficial in Prostate Cancer Therapy?
- Published in:
- Oncology (08909091), 2009, v. 23, n. 7, p. 631
- By:
- Publication type:
- Article
Stereotactic ablative radiation therapy for oligometastatic prostate cancer delays time-to-next systemic treatment.
- Published in:
- World Journal of Urology, 2019, v. 37, n. 12, p. 2623, doi. 10.1007/s00345-018-2477-2
- By:
- Publication type:
- Article
Comparative Survival of Asian and White Metastatic Castration-Resistant Prostate Cancer Men Treated With Docetaxel.
- Published in:
- JNCI Cancer Spectrum, 2020, v. 4, n. 2, p. 1, doi. 10.1093/jncics/pkaa003
- By:
- Publication type:
- Article
Re: Adaptive Therapy for Androgen-Independent Prostate Cancer: A Randomized Selection Trial of Four Regimens.
- Published in:
- 2008
- By:
- Publication type:
- Letter
RESPONSE.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2001, v. 93, n. 15, p. 1175
- By:
- Publication type:
- Article
How Much Can We Rely on the Level of Prostate-Specific Antigen as an End Point for Evaluation of Clinical Trials? A Word of Caution!
- Published in:
- JNCI: Journal of the National Cancer Institute, 1996, v. 88, n. 12, p. 779, doi. 10.1093/jnci/88.12.779
- By:
- Publication type:
- Article
Pain Progression at Initiation of Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Post Hoc Analysis of the PROSELICA Study.
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1284, doi. 10.3390/cancers13061284
- By:
- Publication type:
- Article
The experience with suramin in advanced prostate cancer.
- Published in:
- Cancer (0008543X), 1995, v. 75, n. S7, p. 1927, doi. 10.1002/1097-0142(19950401)75:7+<1927::AID-CNCR2820751628>3.0.CO;2-A
- By:
- Publication type:
- Article
Controversies in the treatment of metastatic prostate cancer.
- Published in:
- Cancer (0008543X), 1992, v. 70, n. S1, p. 324, doi. 10.1002/1097-0142(19920701)70:1+<324::AID-CNCR2820701321>3.0.CO;2-G
- By:
- Publication type:
- Article
A phase II trial of carboplatin and vinblastine in the treatment of advanced squamous cell carcinoma of the esophagus.
- Published in:
- 1991
- By:
- Publication type:
- journal article
A phase 1 study of a chimeric monoclonal antibody against interleukin-6, siltuximab, combined with docetaxel in patients with metastatic castration-resistant prostate cancer.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 3, p. 669, doi. 10.1007/s10637-012-9857-z
- By:
- Publication type:
- Article
TNF-blockade in patients with advanced hormone refractory prostate cancer.
- Published in:
- 2011
- By:
- Publication type:
- Report
Mortality Following Prostate Cancer Recurrence After Radical Prostectomy—Reply.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Risk of Prostate Cancer–Specific Mortality Following Biochemical Recurrence After Radical Prostatectomy.
- Published in:
- JAMA: Journal of the American Medical Association, 2005, v. 294, n. 4, p. 433, doi. 10.1001/jama.294.4.433
- By:
- Publication type:
- Article
Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Antiandrogen withdrawal in castrate-refractory prostate cancer: a Southwest Oncology Group trial (SWOG 9426).
- Published in:
- 2008
- By:
- Publication type:
- journal article
Phase II evaluation of docetaxel plus one-day oral estramustine phosphate in the treatment of patients with androgen independent prostate carcinoma.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Identification and characterization of circulating prostate carcinoma cells.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: Results from a pilot clinical study.
- Published in:
- Science Translational Medicine, 2015, v. 7, n. 269, p. 1, doi. 10.1126/scitranslmed.3010563
- By:
- Publication type:
- Article
Detection of Early Progression with <sup>18</sup>F‐DCFPyL PET/CT in Men with Metastatic Castration‐Resistant Prostate Cancer Receiving Bipolar Androgen Therapy.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.259226
- By:
- Publication type:
- Article
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate- Specific Membrane Antigen (PSMA)-Targeted <sup>18</sup>F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.259069
- By:
- Publication type:
- Article
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen (PSMA)-Targeted 18F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.259069
- By:
- Publication type:
- Article
Detection of Early Progression with 18F‐DCFPyL PET/CT in Men with Metastatic Castration‐Resistant Prostate Cancer Receiving Bipolar Androgen Therapy.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.259226
- By:
- Publication type:
- Article
Detection of Early Progression with <sup>18</sup>F‐DCFPyL PET/CT in Men with Metastatic Castration‐Resistant Prostate Cancer Receiving Bipolar Androgen Therapy.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.259226
- By:
- Publication type:
- Article
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on ProstateSpecific Membrane Antigen (PSMA)-Targeted <sup>18</sup>F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide .
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.259069
- By:
- Publication type:
- Article
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen (PSMA)-Targeted <sup>18</sup>F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.259069
- By:
- Publication type:
- Article
Detection of Early Progression with <sup>18</sup>F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.259226
- By:
- Publication type:
- Article
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen (PSMA)-Targeted <sup>18</sup>F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.259069
- By:
- Publication type:
- Article
Detection of Early Progression with <sup>18</sup>F-DCFPvL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.259226
- By:
- Publication type:
- Article
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate- Specific Membrane Antigen (PSMA)-Targeted <sup>18</sup>F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 33, doi. 10.2967/jnumed.120.259069
- By:
- Publication type:
- Article
Detection of Early Progression with <sup>18</sup>F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.120.259226
- By:
- Publication type:
- Article
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen (PSMA)-Targeted <sup>18</sup>F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.259069
- By:
- Publication type:
- Article